M. Pynka

Infection with HIV-1 subtype D adversely affects the live expectancy independently of antiretroviral drug use.

A. Urbańska, M. Parczewski, B. Aksak-Wąs, 2021, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Disseminated infection withSaccharomyces kluyveri in a patient with AIDS

D. Bander, M. Syczewska, A. Wnuk, 1998, Infection.

Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients

Anne M Johnson, A. Trkola, J. Sterne, 2007, Journal of acquired immune deficiency syndromes.

Liver-related death among HIV/HCV coinfected indivi duals, implications for the era of directly acting ant ivirals

P. Vanhems, O. Kirk, R. Paredes, 2014 .

Changing utilization of Stavudine (d4T) in HIV‐positive people in 2006–2013 in the EuroSIDA study

J. Nielsen, C. Leen, P. Vanhems, 2015, HIV medicine.

Long‐term effectiveness of recommended boosted protease inhibitor‐based antiretroviral therapy in Europe

A. Mocroft, A. Blaxhult, J. Lundgren, 2018, HIV medicine.